ArticleThe Journal of experimental medicine2002

Targeted deletion of a high-affinity GATA-binding site in the GATA-1 promoter leads to selective loss of the eosinophil lineage in vivo.

Channing Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.